225 related articles for article (PubMed ID: 23382787)
1. Molecular imaging of chemokine receptor CXCR4.
Weiss ID; Jacobson O
Theranostics; 2013; 3(1):76-84. PubMed ID: 23382787
[TBL] [Abstract][Full Text] [Related]
2. Imaging CXCL12-CXCR4 signaling in ovarian cancer therapy.
Salomonnson E; Stacer AC; Ehrlich A; Luker KE; Luker GD
PLoS One; 2013; 8(1):e51500. PubMed ID: 23372646
[TBL] [Abstract][Full Text] [Related]
3. Molecular Imaging of the Chemokine Receptor CXCR4 After Acute Myocardial Infarction.
Thackeray JT; Derlin T; Haghikia A; Napp LC; Wang Y; Ross TL; Schäfer A; Tillmanns J; Wester HJ; Wollert KC; Bauersachs J; Bengel FM
JACC Cardiovasc Imaging; 2015 Dec; 8(12):1417-1426. PubMed ID: 26577262
[TBL] [Abstract][Full Text] [Related]
4. Imaging agents for the chemokine receptor 4 (CXCR4).
Kuil J; Buckle T; van Leeuwen FW
Chem Soc Rev; 2012 Aug; 41(15):5239-61. PubMed ID: 22743644
[TBL] [Abstract][Full Text] [Related]
5. CXCR4-based imaging agents.
Woodard LE; Nimmagadda S
J Nucl Med; 2011 Nov; 52(11):1665-9. PubMed ID: 22045705
[TBL] [Abstract][Full Text] [Related]
6. Positron emission tomography imaging of tumors expressing the human chemokine receptor CXCR4 in mice with the use of 64Cu-AMD3100.
Weiss ID; Jacobson O; Kiesewetter DO; Jacobus JP; Szajek LP; Chen X; Farber JM
Mol Imaging Biol; 2012 Feb; 14(1):106-14. PubMed ID: 21347799
[TBL] [Abstract][Full Text] [Related]
7. The intricate role of CXCR4 in cancer.
Chatterjee S; Behnam Azad B; Nimmagadda S
Adv Cancer Res; 2014; 124():31-82. PubMed ID: 25287686
[TBL] [Abstract][Full Text] [Related]
8. Chemokine receptor - Directed imaging and therapy.
Buck AK; Stolzenburg A; Hänscheid H; Schirbel A; Lückerath K; Schottelius M; Wester HJ; Lapa C
Methods; 2017 Nov; 130():63-71. PubMed ID: 28916148
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive imaging reveals inhibition of ovarian cancer by targeting CXCL12-CXCR4.
Ray P; Lewin SA; Mihalko LA; Schmidt BT; Luker KE; Luker GD
Neoplasia; 2011 Dec; 13(12):1152-61. PubMed ID: 22241961
[TBL] [Abstract][Full Text] [Related]
10. In vivo imaging of ligand receptor binding with Gaussia luciferase complementation.
Luker KE; Mihalko LA; Schmidt BT; Lewin SA; Ray P; Shcherbo D; Chudakov DM; Luker GD
Nat Med; 2011 Dec; 18(1):172-7. PubMed ID: 22138753
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of N-[(11)C]methyl-AMD3465 as a PET tracer for imaging of CXCR4 receptor expression in a C6 glioma tumor model.
Hartimath SV; van Waarde A; Dierckx RA; de Vries EF
Mol Pharm; 2014 Nov; 11(11):3810-7. PubMed ID: 25094028
[TBL] [Abstract][Full Text] [Related]
12. In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma.
Philipp-Abbrederis K; Herrmann K; Knop S; Schottelius M; Eiber M; Lückerath K; Pietschmann E; Habringer S; Gerngroß C; Franke K; Rudelius M; Schirbel A; Lapa C; Schwamborn K; Steidle S; Hartmann E; Rosenwald A; Kropf S; Beer AJ; Peschel C; Einsele H; Buck AK; Schwaiger M; Götze K; Wester HJ; Keller U
EMBO Mol Med; 2015 Apr; 7(4):477-87. PubMed ID: 25736399
[TBL] [Abstract][Full Text] [Related]
13. Pentixafor PET/CT for imaging of chemokine receptor 4 expression in esophageal cancer - a first clinical approach.
Linde P; Baues C; Wegen S; Trommer M; Quaas A; Rosenbrock J; Celik E; Marnitz S; Bruns CJ; Fischer T; Schomaecker K; Wester HJ; Drzezga A; van Heek L; Kobe C
Cancer Imaging; 2021 Feb; 21(1):22. PubMed ID: 33579381
[TBL] [Abstract][Full Text] [Related]
14. Molecular imaging of CXCR4 receptor expression in human cancer xenografts with [64Cu]AMD3100 positron emission tomography.
Nimmagadda S; Pullambhatla M; Stone K; Green G; Bhujwalla ZM; Pomper MG
Cancer Res; 2010 May; 70(10):3935-44. PubMed ID: 20460522
[TBL] [Abstract][Full Text] [Related]
15. Use of a single hybrid imaging agent for integration of target validation with in vivo and ex vivo imaging of mouse tumor lesions resembling human DCIS.
Buckle T; Kuil J; van den Berg NS; Bunschoten A; Lamb HJ; Yuan H; Josephson L; Jonkers J; Borowsky AD; van Leeuwen FW
PLoS One; 2013; 8(1):e48324. PubMed ID: 23326303
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomographic imaging of CXCR4 in cancer: challenges and promises.
George GP; Pisaneschi F; Nguyen QD; Aboagye EO
Mol Imaging; 2014; 13():. PubMed ID: 25341373
[TBL] [Abstract][Full Text] [Related]
17. Bioluminescent CXCL12 fusion protein for cellular studies of CXCR4 and CXCR7.
Luker K; Gupta M; Luker G
Biotechniques; 2009 Jul; 47(1):625-32. PubMed ID: 19594447
[TBL] [Abstract][Full Text] [Related]
18. The chemokine receptors CXCR4/CXCR7 and their primary heterodimeric ligands CXCL12 and CXCL12/high mobility group box 1 in pancreatic cancer growth and development: finding flow.
Shakir M; Tang D; Zeh HJ; Tang SW; Anderson CJ; Bahary N; Lotze MT
Pancreas; 2015 May; 44(4):528-34. PubMed ID: 25872129
[TBL] [Abstract][Full Text] [Related]
19. Improvement of CXCR4 tracer specificity for PET imaging.
Jacobson O; Weiss ID; Szajek LP; Niu G; Ma Y; Kiesewetter DO; Peled A; Eden HS; Farber JM; Chen X
J Control Release; 2012 Jan; 157(2):216-23. PubMed ID: 21964282
[TBL] [Abstract][Full Text] [Related]
20. Targeting CXCR4 (CXC Chemokine Receptor Type 4) for Molecular Imaging of Aldosterone-Producing Adenoma.
Heinze B; Fuss CT; Mulatero P; Beuschlein F; Reincke M; Mustafa M; Schirbel A; Deutschbein T; Williams TA; Rhayem Y; Quinkler M; Rayes N; Monticone S; Wild V; Gomez-Sanchez CE; Reis AC; Petersenn S; Wester HJ; Kropf S; Fassnacht M; Lang K; Herrmann K; Buck AK; Bluemel C; Hahner S
Hypertension; 2018 Feb; 71(2):317-325. PubMed ID: 29279316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
